Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation

Cardiovascular Division, Washington University School of Medicine, Saint Saint Louis, Missouri.

OBJECTIVES. This study was designed to characterize immediate, early and long-term changes in right ventricular structure and function, as defined by two-dimensional and Doppler echocardiography, after single-lung transplantation in patients with severe pulmonary hypertension. BACKGROUND. Single-lung transplantation has recently been shown to dramatically improve hemodynamics in patients with primary pulmonary hypertension who had unsuccessful medical therapy. METHODS. Fourteen patients with severe pulmonary hypertension who underwent single-lung transplantation were studied with transthoracic and transesophageal two-dimensional and Doppler echocardiography. Right ventricular dimensions were measured in the apical four-chamber view. Right ventricular ejection and acceleration times and peak velocity of tricuspid regurgitation were measured by Doppler study. Results of right heart catheterization were available early (< 3 months) after transplantation in 10 of 13 patients and late after transplantation (6 months to 2 years) in 11 patients. RESULTS. In the early posttransplantation studies, right ventricular dimensions decreased and fractional area change and ejection fraction increased in all patients, but right ventricular wall thickness did not change significantly. Tricuspid regurgitation lessened markedly in all patients. Long-term decreases in right ventricular dimension and improvement in systolic function were sustained. Right ventricular wall thickness significantly decreased compared with the early postoperative value (0.76 +/- 0.1 cm compared with 0.63 +/- 0.14 cm, p < 0.02). CONCLUSIONS. Two-dimensional echocardiography demonstrates sustained improvement in right ventricular function after single-lung transplantation for severe pulmonary hypertension despite severe preoperative dysfunction.

This article has been cited by other articles:

				A. Vonk Noordegraaf and N. Galie The role of the right ventricle in pulmonary arterial hypertension Eur. Respir. Rev., December 1, 2011; 20(122): 243 - 253. [Abstract] [Full Text] [PDF]

				L. L. Schulman and M. Estenne Effects of transplantation on lung and exercise physiology Lung Transplantation, July 1, 2010; 220 - 242. [Abstract] [Fulltext] [PDF]

				M. Delcroix, N. W. Morrell, M. Abramowicz, O. Sitbon, A. Boonstra, N. Galie, E. Grunig, P. Herve, R. C. Trembath, A. J. Peacock, et al. Pulmonary arterial hypertension: genetics, reversibility testing and follow-up Pulmonary Vascular Pathology: a Clinical Update, June 28, 2010; 33 - 56. [Abstract] [Fulltext] [PDF]

				M. Delcroix, W. Budts, P. A. Corris, W. Daenen, M. Gewillig, R. Naeije, H. Olschewski, J. Pepke-Zaba, W. Seeger, J.-L. Vachiery, et al. Pulmonary arterial hypertension: current therapies Pulmonary Vascular Pathology: a Clinical Update, June 28, 2010; 57 - 83. [Abstract] [Fulltext] [PDF]

				H. J. Bogaard, K. Abe, A. Vonk Noordegraaf, and N. F. Voelkel The Right Ventricle Under Pressure: Cellular and Molecular Mechanisms of Right-Heart Failure in Pulmonary Hypertension Chest, March 1, 2009; 135(3): 794 - 804. [Abstract] [Full Text] [PDF]

				J.G. Coghlan and J. Davar How should we assess right ventricular function in 2008? Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H22 - H28. [Abstract] [Full Text] [PDF]

				G. Yung Lung Transplantation and Pulmonary Hypertension Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 149 - 156. [Abstract] [PDF]

				N. F. Voelkel, R. A. Quaife, L. A. Leinwand, R. J. Barst, M. D. McGoon, D. R. Meldrum, J. Dupuis, C. S. Long, L. J. Rubin, F. W. Smart, et al. Right Ventricular Function and Failure: Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure Circulation, October 24, 2006; 114(17): 1883 - 1891. [Full Text] [PDF]

				M.-T. Kasimir, G. Seebacher, P. Jaksch, G. Winkler, K. Schmid, G. M. Marta, P. Simon, and W. Klepetko Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation Eur J Cardiothorac Surg, October 1, 2004; 26(4): 776 - 781. [Abstract] [Full Text] [PDF]

				R. L. Doyle, D. McCrory, R. N. Channick, G. Simonneau, and J. Conte Surgical Treatments/Interventions for Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 63S - 71S. [Abstract] [Full Text] [PDF]

				N. Galie, A. L. Hinderliter, A. Torbicki, T. Fourme, G. Simonneau, T. Pulido, N. Espinola-Zavaleta, G. Rocchi, A. Manes, R. Frantz, et al. Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertension J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1380 - 1386. [Abstract] [Full Text] [PDF]

				T. Menzel, T. Kramm, S. Wagner, S. Mohr-Kahaly, E. Mayer, and J. Meyer Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy Ann. Thorac. Surg., March 1, 2002; 73(3): 756 - 761. [Abstract] [Full Text] [PDF]

				M. M. Chakinala, M. H. Kollef, and E. P. Trulock Critical Care Aspects of Lung Transplant Patients J Intensive Care Med, January 1, 2002; 17(1): 8 - 33. [Abstract] [PDF]

				T. Menzel, S. Wagner, T. Kramm, S. Mohr-Kahaly, E. Mayer, S. Braeuninger, and J. Meyer Pathophysiology of Impaired Right and Left Ventricular Function in Chronic Embolic Pulmonary Hypertension : Changes After Pulmonary Thromboendarterectomy Chest, October 1, 2000; 118(4): 897 - 903. [Abstract] [Full Text] [PDF]

				V. G. Davila-Roman, A. D. Waggoner, W. E. Hopkins, and B. Barzilai Right ventricular dysfunction in low output syndrome after cardiac operations: Assessment by transesophageal echocardiography Ann. Thorac. Surg., October 1, 1995; 60(4): 1081 - 1086. [Abstract] [PDF]